Veralox Therapeutics Inc.

Biotechnology company · Frederick, Maryland, United States

Veralox Therapeutics Inc. is a biotechnology company headquartered in Frederick, Maryland, United States. Its earliest recorded incorporation is in 2018. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $619,133 in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $24 million sold in a notice filed in 2023.

veralox.comProfile compiled from public records. Is this your company? Request a correction or update

Veralox Therapeutics at a glance

Typebiotechnology company
HeadquartersFrederick, Maryland, United States
Earliest incorporation on record2018
Employees (per SBIR records)4
SEC CIK1777474

What does Veralox Therapeutics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $619,133 in total (2018 to 2020). NIH funding came from the National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $24 million sold (2023).

Frequently asked questions about Veralox Therapeutics

Where is Veralox Therapeutics headquartered?

Veralox Therapeutics Inc. is headquartered in Frederick, Maryland, United States.

What does Veralox Therapeutics do?

Veralox Therapeutics Inc. is a biotechnology company.

When was Veralox Therapeutics founded?

The earliest incorporation on record for Veralox Therapeutics Inc. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.